AI-CARE: Artificial Intelligence for Cardiovascular Analysis and Risk Evaluation
AI-CARE
1 other identifier
observational
240
2 countries
3
Brief Summary
This study will test how well an artificial intelligence (AI) software called Aorta AIM measures the size of the aorta (the body's main blood vessel) from CT scans. The aorta can become enlarged over time, which may lead to serious health problems. Doctors need to measure the aorta accurately to monitor patients and decide on treatment. Currently, doctors measure the aorta manually on CT scans, which takes time and can vary between different doctors. Aorta AIM is designed to measure the aorta automatically and consistently. In this study, researchers will compare Aorta AIM's measurements to those made by experienced radiologists or cardiologists (doctors who specialize in reading medical images). The study will use CT scans that have already been taken as part of routine medical care - no additional scans or procedures are needed. The study will include approximately 250 participants across multiple hospitals in Brazil and the United States. Participants will be adults who have had a chest or abdominal CT scan that shows their aorta. The main goals are to:
- Check if Aorta AIM measures the aorta as accurately as radiologists
- See if Aorta AIM can help doctors work more efficiently
- Evaluate if the software works well in different hospital settings and with different types of patients This research may help improve how doctors monitor aortic disease and make treatment decisions in the future. There are no risks to participants since the study only uses existing medical images.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2026
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2026
CompletedFirst Submitted
Initial submission to the registry
February 23, 2026
CompletedFirst Posted
Study publicly available on registry
February 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
September 5, 2026
ExpectedFebruary 27, 2026
February 1, 2026
6 months
February 23, 2026
February 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Mean Absolute Error (MAE) between Aorta AIM measurements and expert reference standard
Mean Absolute Error (MAE) between aortic diameter measurements generated by Aorta AIM version 1.0 and the reference standard established by board-certified or equivalently experienced expert radiologists performing manual annotations. MAE will be calculated across all anatomical regions of the aorta assessed in the study.
At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)
Secondary Outcomes (5)
Bland-Altman Limits of Agreement
At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)
Intraclass Correlation Coefficient (ICC)
At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)
Processing success rate
At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)
Processing time
At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)
Qualitative clinical acceptability scores by expert readers
At time of CT scan analysis (single time point, retrospective data collection from studies performed January 1, 2016 through August 31, 2025)
Study Arms (1)
Validation Cohort
Adults who have undergone chest or abdominal CT imaging (with or without contrast) as part of routine clinical care. CT scans will be retrospectively collected and processed by both Aorta AIM software and expert radiologists to validate automated aortic diameter measurements.
Interventions
Manual aortic diameter measurements performed by experienced radiologists (minimum 5 years of cardiovascular imaging experience) using standard clinical measurement techniques on the same CT scans analyzed by Aorta AIM software. These measurements serve as the reference standard for validation.
Aorta AIM is an investigational artificial intelligence software that automatically measures aortic diameters from CT imaging. The software analyzes retrospectively collected CT scans and generates standardized aortic diameter measurements at anatomically defined locations. These automated measurements will be compared to manual measurements performed by expert radiologists.
Eligibility Criteria
Adult patients (≥22 years of age) who underwent CT imaging of the aorta (whole, thoracic, or abdominal) as part of routine clinical care between January 1, 2016 and August 31, 2025. CT scans must include imaging of the aorta with or without contrast enhancement and have slice thickness ≤3mm. Patients with metal implants within 5cm of the aorta, prior aortic surgery, severe motion artifacts, congenital aortic anomalies, or post-traumatic aortic repairs are excluded. Patients who opted out of having their data used for medical research are also excluded. Retrospectively collected, de-identified CT imaging data from approximately 250 cases across multiple international sites in the United States and Latin America will be analyzed.
You may qualify if:
- Adults ≥22 years at time of imaging
- Studies performed 1 Jan 2016 - 31 August 2025
- CT imaging of whole, thoracic, or abdominal aorta with or without contrast enhancement:
- Non-contrast: cardiac-gated or non-gated
- Contrast-enhanced: cardiac-gated thoracic and/or non gated abdominal
- Slice thickness ≤ 3mm
You may not qualify if:
- Metal implants \<5cm from aorta (e.g. thoracic stent)
- Prior aortic surgery
- Severe motion artifacts (e.g. \>3mm vessel blurring)
- Congenital aortic anomalies (e.g. coarctation, vascular rings)
- Post-traumatic aortic repairs
- The patient opted out of having their data used for medical research before the date of cross-referencing by the site team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aiatella Oylead
Study Sites (3)
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Innovation Health Services
Norfolk, Virginia, 23510, United States
Hospital Israelita Albert Einstein
São Paulo, São Paulo, 05652-900, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jack Parker
Aiatella Oy
- PRINCIPAL INVESTIGATOR
Scott Flamm
SimonMed Imaging
Central Study Contacts
Scott Flamm, MD
CONTACT
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 23, 2026
First Posted
February 27, 2026
Study Start
February 2, 2026
Primary Completion
July 30, 2026
Study Completion (Estimated)
September 5, 2026
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
This is a retrospective medical device validation study using de-identified CT imaging data. Individual participant data cannot be shared due to patient privacy protections, institutional data use agreements, and proprietary algorithm considerations. Aggregate study results, including device performance metrics and statistical analyses, will be made publicly available through peer-reviewed publication and regulatory submissions.